Healthcare provider profile · identity verified

Vimla R Maiki, PA

Physician Assistant · STOCKBRIDGE, GA · NPI 1447464243

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	399	274
Amlodipine Besylate	Amlodipine Besylate	312	215
Levothyroxine Sodium	Levothyroxine Sodium	232	160
Losartan Potassium	Losartan Potassium	178	117
Rosuvastatin Calcium	Rosuvastatin Calcium	176	118
Lisinopril	Lisinopril	144	98
Hydrochlorothiazide	Hydrochlorothiazide	118	79
Metformin Hcl	Metformin Hcl	102	71
Simvastatin	Simvastatin	91	58
Omeprazole	Omeprazole	88	67
Trazodone Hcl	Trazodone Hcl	86	52
Pravastatin Sodium	Pravastatin Sodium	80	54
Potassium Chloride	Potassium Chloride	77	46
Allopurinol	Allopurinol	74	44
Albuterol Sulfate Hfa	Albuterol Sulfate	73	47
Pantoprazole Sodium	Pantoprazole Sodium	72	50
Sertraline Hcl	Sertraline Hcl	66	46
Metoprolol Succinate	Metoprolol Succinate	65	47
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	63	43
Gabapentin	Gabapentin	60	48
Tamsulosin Hcl	Tamsulosin Hcl	60	45
Furosemide	Furosemide	58	35
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	36
Fluticasone Propionate	Fluticasone Propionate	53	36
Eliquis	Apixaban	52	24
Ozempic	Semaglutide	52	28
Famotidine	Famotidine	46	30
Metformin Hcl Er	Metformin Hcl	46	35
Duloxetine Hcl	Duloxetine Hcl	45	28
Escitalopram Oxalate	Escitalopram Oxalate	43	33
Montelukast Sodium	Montelukast Sodium	43	32
Ezetimibe	Ezetimibe	42	26
Atenolol	Atenolol	41	32
Carvedilol	Carvedilol	40	31
Citalopram Hbr	Citalopram Hydrobromide	36	26
Clopidogrel	Clopidogrel Bisulfate	36	26
Hydralazine Hcl	Hydralazine Hcl	36	25
Metoprolol Tartrate	Metoprolol Tartrate	36	26
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	28
Alendronate Sodium	Alendronate Sodium	27	19
Diclofenac Sodium	Diclofenac Sodium	27	18
Spironolactone	Spironolactone	27	18
Meloxicam	Meloxicam	26	23
Tramadol Hcl	Tramadol Hcl	26	21
Glimepiride	Glimepiride	24	18
Donepezil Hcl	Donepezil Hcl	22	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	16
Tizanidine Hcl	Tizanidine Hcl	21	14
Doxazosin Mesylate	Doxazosin Mesylate	20	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	15
Fluoxetine Hcl	Fluoxetine Hcl	19	16
Irbesartan	Irbesartan	19	12
Synthroid	Levothyroxine Sodium	19	14
Valacyclovir	Valacyclovir Hcl	19	13
Dropsafe Prep Pads	Alcohol Antiseptic Pads	18	11
Finasteride	Finasteride	18	11
Glipizide	Glipizide	18	16
Jardiance	Empagliflozin	18	suppressed
Mirtazapine	Mirtazapine	18	15
Olmesartan Medoxomil	Olmesartan Medoxomil	18	14
Fenofibrate	Fenofibrate	17	11
Memantine Hcl	Memantine Hcl	17	12
Trulicity	Dulaglutide	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	13
Zolpidem Tartrate	Zolpidem Tartrate	17	15
Bupropion Xl	Bupropion Hcl	16	11
Lovastatin	Lovastatin	16	suppressed
Mounjaro	Tirzepatide	16	12
Pregabalin	Pregabalin	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	13
Hydroxyzine Hcl	Hydroxyzine Hcl	15	11
Valsartan	Valsartan	15	11
Chlorthalidone	Chlorthalidone	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	11
Celecoxib	Celecoxib	13	13
Glipizide Er	Glipizide	13	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Nifedipine Er	Nifedipine	12	11
Azelastine Hcl	Azelastine Hcl	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error